Clinical trial
Efficacy and Safety of Irregular Pulsed Radiofrequency (Sluijter-Teixera Poisson) Versus Regular Pulsed Radiofrequency to the Gasserian Ganglion for Treatment of Primary Trigeminal Neuralgia
NCT07275229 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Irregular Pulsed Radiofrequency (Sluijter-Teixera Poisson) Versus Regular Pulsed Radiofrequency to the Gasserian Ganglion for Treatment of Primary Trigeminal Neuralgia
- Lead sponsor
- Sohag University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 31, 2025
- Completion date
- April 30, 2027
- Enrollment
- 62 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.